JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1990; 70:262-266
© 1990 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santos, A. C.
Right arrow Articles by Covino, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santos, A. C.
Right arrow Articles by Covino, B. G.

Pharmacokinetics of Ropivacaine in Nonpregnant and Pregnant Ewes

Alan C. Santos, MD, Hilda Pedersen, MD, John A. Sallusto, MD, H. Vernetta Johnson, MD, Hisayo O. Morishima, MD, PhD, Mieczyslaw Finster, MD, G. Richard Arthur, PhD, and Benjamin G. Covino, PhD, MD

Received from the Departments of Anesthesiology and of Obstetrics and Gynecology, School of Medicine, State University of New York—Stony Brook, Stony Brook, New York; the College of Physicians & Surgeons of Columbia University, New York, New York; the Department of Aresthesiology, State University of New York—Downstate Medical Center, Brooklyn, New York; and the Department of Anesthesia, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.

Abstract

The pharmacokinetics of ropivacaine were studied in chronically instrumented nonpregnant and pregnant ewes. On the day of study, the urinary bladder was catheterized. Ropivacaine (2.5 or 3.0 mg/kg) was administered by intravenous infusion over 2 or 4 min. Serial samples of arterial blood and urine were collected over 5 h, and drug concentrations were determined using a gas chromatographic technique. Total clearance of ropivacaine was lower in the pregnant animals (21.6 ± 4.5 mL·min–1 ·kg–1) compared with the nonpregnant animals (45.1 ± 6.7 mL·min–1 ·kg–1). There was a tendency toward a decrease in the volume of distribution during the terminal exponential phase of drug elimination of 2.03 ± 0.36 L/kg in the pregnant and 4.32 ± 1.03 L/kg in the nonpregnant sheep. Thus the difference in the elimination half-life was only minimal: 74.7 ± 10.7 min in the pregnant and 64.4 ± 7.4 min in the nonpregnant animals. It is concluded that ovine pregnancy is accompanied by changes in the pharmacoki- netics of ropivacaine. Inadvertent intravenous injections of similar drug doses to pregnant and nonpregnant women might result in higher plasma concentrations of ropivacaine in the former. However, the rate of decline in plasma levels of the drug would be similar in both.

Key Words: ANESTHETICS, LOCAL—ropivacaine • PHARMACOKINETICS, ROPIVACAINE • PREGNANCY, PHARMACOKINETICS—ropivacaine • ANESTHESIA, OBSTETRICAL







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1990 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1990 by the International Anesthesia Research Society.